Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Djulbegovic

Showing results (111-120 of 315) with videos related to

Pageof 32
Sort By:
Journal of Evaluation in Clinical Practice|April 24, 2019
Failure to place evidence at the centre of quality improvement remains a major barrier for advances in quality improvementBenjamin Djulbegovic, Charles L Bennett, Gordon Guyatt
Cancer Control : Journal of the Moffitt Cancer Center|April 2, 2009
Epistemologic inquiries in evidence-based medicineBenjamin Djulbegovic, Gordon H Guyatt, Richard E Ashcroft
Plos One|August 15, 2014
Evolution of treatment regimens in multiple myeloma: a social network analysisHelen Mahony, Athanasios Tsalatsanis, Ambuj Kumar, et al.
European Journal of Clinical Investigation|November 22, 2014
Modern health care as a game theory problemBenjamin Djulbegovic, Iztok Hozo, John P A Ioannidis
The Cochrane Database of Systematic Reviews|December 19, 2017
Bisphosphonates in multiple myeloma: an updated network meta-analysisRahul Mhaskar, Ambuj Kumar, Branko Miladinovic, et al.
JAMA|May 22, 2014
Study design and the drug development process--replyJohn P A Ioannidis, Iztok Hozo, Benjamin Djulbegovic
American Journal of Hematology|December 2, 2010
Thalidomide versus bortezomib based regimens as first-line therapy for patients with multiple myeloma: a systematic reviewAmbuj Kumar, Iztok Hozo, Keath Wheatley, et al.
JAMA Network Open|December 8, 2022
Federal Funding and Citation Metrics of US Biomedical Researchers, 1996 to 2022John P A Ioannidis, Iztok Hozo, Benjamin Djulbegovic
Plos One|August 6, 2015
Dual Processing Model for Medical Decision-Making: An Extension to Diagnostic TestingAthanasios Tsalatsanis, Iztok Hozo, Ambuj Kumar, et al.
Plos One|November 3, 2010
JAMA published fewer industry-funded studies after introducing a requirement for independent statistical analysisElizabeth Wager, Rahul Mhaskar, Stephanie Warburton, et al.
Pageof 32

Showing results (111-120 of 315) with videos related to

Sort By:
Pageof 32
Journal of Evaluation in Clinical Practice|April 24, 2019
Failure to place evidence at the centre of quality improvement remains a major barrier for advances in quality improvementBenjamin Djulbegovic, Charles L Bennett, Gordon Guyatt
Cancer Control : Journal of the Moffitt Cancer Center|April 2, 2009
Epistemologic inquiries in evidence-based medicineBenjamin Djulbegovic, Gordon H Guyatt, Richard E Ashcroft
Plos One|August 15, 2014
Evolution of treatment regimens in multiple myeloma: a social network analysisHelen Mahony, Athanasios Tsalatsanis, Ambuj Kumar, et al.
European Journal of Clinical Investigation|November 22, 2014
Modern health care as a game theory problemBenjamin Djulbegovic, Iztok Hozo, John P A Ioannidis
The Cochrane Database of Systematic Reviews|December 19, 2017
Bisphosphonates in multiple myeloma: an updated network meta-analysisRahul Mhaskar, Ambuj Kumar, Branko Miladinovic, et al.
JAMA|May 22, 2014
Study design and the drug development process--replyJohn P A Ioannidis, Iztok Hozo, Benjamin Djulbegovic
American Journal of Hematology|December 2, 2010
Thalidomide versus bortezomib based regimens as first-line therapy for patients with multiple myeloma: a systematic reviewAmbuj Kumar, Iztok Hozo, Keath Wheatley, et al.
JAMA Network Open|December 8, 2022
Federal Funding and Citation Metrics of US Biomedical Researchers, 1996 to 2022John P A Ioannidis, Iztok Hozo, Benjamin Djulbegovic
Plos One|August 6, 2015
Dual Processing Model for Medical Decision-Making: An Extension to Diagnostic TestingAthanasios Tsalatsanis, Iztok Hozo, Ambuj Kumar, et al.
Plos One|November 3, 2010
JAMA published fewer industry-funded studies after introducing a requirement for independent statistical analysisElizabeth Wager, Rahul Mhaskar, Stephanie Warburton, et al.
Pageof 32